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Renal cell carcinoma accounts for 2% of all adult
malignancies [1]. This cancer exhibits a highly variable
constellation of presenting signs and symptoms, and, in 25%
e40% of cases, is actually diagnosed as an incidental finding
[1]. In patients with localized disease at presentation and
who are treated surgically, distant metastases still develop in
20%e50% [1e4]. Although 85% of relapses occur within 3
years, recurrence may occur over an unpredictable time
frame, up to and beyond 10 years after resection [1].
Common sites of recurrence include lung, liver, bone, and
brain. However, this cancer also has a predilection for
reappearing in unusual sites, presenting both clinical and
radiologic diagnostic challenges if the original diagnosis is
not borne in mind. If detected in a timely manner, then such
isolated metastases may be curatively resected [4,5]. Survival
advantage is conferred on those with a longer disease-free
interval and a single site of recurrence [4,5]. This pictorial
review of unusual sites of disease recurrence, both local and
metastatic, diagnosed at our institution, highlights the need
for an awareness of the variety of atypical manifestations of
renal cell carcinoma recurrence.Methods
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of 634 patients. The majority of these patients were found
to have local nephrectomy bed recurrence of tumour or
disease metastatic to the typical sites, such as lung or bone.
The more unusual and unexpected patterns of disease
recurrence were subselected for this pictorial review. We
illustrate the imaging features of an extensive array of
atypical locations of renal cell carcinoma metastases and
unusual manifestations of local recurrence on computed
tomography (CT), magnetic resonance imaging (MRI),
ultrasound, positron emission tomographyeCT, and plain
film.Typical Patterns of Renal Cell Carcinoma Metastases
Up to 30% of patients have metastatic disease at the time
of initial diagnosis, and the most commonly involved sites
are lung (50%e60% of those with metastatic disease), liver
(30%e40%), bone (30%e40%), and brain (5%) [1].
Occurrence of delayed metastatic disease is common,
affecting 30%e50% [4] of patients, and the typical sites of
involvement are similar. Although the single metastasis is
desirable for surgical management, disease recurrence is
often multifocal [2].
Contrast-enhanced multidetector CT is the imaging
modality of choice in the follow-up of renal cell carcinoma.
Metastases of this vascular tumour are also typically hyper-
vascular, and the protocol for optimizing detection of
recurrent disease should involve imaging of the abdomen and
pelvis first in the arterial phase, followed by scanning the
thorax from lung apices to below both kidneys in the portal
venous phase of imaging [2,6].ll rights reserved.
Figure 1. A 62-year-old woman with a history of right nephrectomy 5 years
earlier for clear cell renal cell carcinoma. Arterial phase of contrast-
enhanced computed tomography shows histologically confirmed, hyper-
vascular metastasis in the head of the pancreas (black arrow).
Figure 2. A 67-year-old man with a history of nephrectomy for renal cell
carcinoma 13 years earlier. Arterial phase of contrast-enhanced computed
tomography shows avidly enhancing mass, consistent with renal cell
carcinoma metastasis in head of pancreas (black arrow) on the coronal
reformatted image.
Figure 3. A 56-year-old man with a history of left nephrectomy for renal cell
carcinoma 3 years earlier. Isolated metastasis to the tail of the pancreas
(white arrow) identified on the arterial phase of contrast-enhanced computed
tomography and confirmed by histology.
Figure 4. A 60-year-old man who underwent nephrectomy for renal cell
carcinoma 8 years earlier. Arterial phase of contrast-enhanced computed
tomography, demonstrating enhancing metastasis in the spleen (black
arrow).
Figure 5. A 72-year-old patient with a history of right nephrectomy 5 years
earlier. Bilateral adrenal masses consistent with bilateral adrenal metastases
diagnosed on follow-up computed tomography (black arrows [2]), coronal
reformatted image.
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Figure 6. A 65-year-old patient with a history of right nephrectomy for renal
cell carcinoma 3 years earlier. The arterial phase of the contrast-enhanced
computed tomography demonstrates metastatic disease in the gallbladder
(black arrow) and right adrenal gland (white arrow).
Figure 8. A 64-year-old woman with a history of nephrectomy 2 years
earlier. A large, necrotic, enhancing mass (black arrow) in the region of the
left nephrectomy bed, fistulating (white arrow) into the adjacent large bowel
is demonstrated on contrast-enhanced computed tomography. At colono-
scopy, suture material was identified at the site of the mass, through the
fistula. Biopsy confirmed recurrence of the patient’s original renal cancer.
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Metastatic
The route of spread of renal cell carcinoma may be
hematogenous, lymphatic, direct local extension into the
perirenal fat, or direct extension into the renal vein and from
there to the inferior vena cava. Unusual pathways of spread
possibly represent various manifestations of the hematoge-
nous spread of this tumour. For example, bypassing the lungs
via the paravertebral venous plexus of Batson is postulated to
allow distant head and neck metastasis. In the case of vaginalFigure 7. (A) A 50-year-old woman with a history of radical left nephrectomy fo
Contrast-enhanced computed tomography (CT), showing stented common bile du
specimens taken at endoscopic retrograde cholangiopancreatography were consi
image of portal venous phase of contrast-enhanced CT, demonstrating the ampuand adnexal metastases, retrograde venous extension is
considered the most likely explanation [7]. The following
examples of unusual sites of disease recurrence, both local
and distant, highlight the unpredictability of this tumour and
its path of spread.Pancreatic MetastasesMetastatic disease to the pancreas (Figures 1e3) from any
primary tumour is quite rare, with only 2%e11% of all
pancreatic malignancies being found to be nonprimary inr renal cell carcinoma presented with jaundice 2 years after a nephrectomy.
ct and ampullary mass (black arrow), on sagittal reformatted image. Biopsy
stent with clear cell renal cell carcinoma recurrence. (B) Axial reformatted
llary mass in this same patient (black arrow).
Figure 9. A 68-year-old woman with a history of nephrectomy 3 years
earlier, presented with foul-smelling discharge from between the 11th and
12th ribs, the exit site of her postoperative drain. Coronal reconstruction of
contrast-enhanced computed tomography shows histologically proven,
recurrent disease fistulating along the clearly defined path of the previous
drain (black arrow).
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metastasize to this organ; this occurs in only 1%e3% of all
cases [8]. Such metastases may be uni- or multifocal and,
unlike primary ductal adenocarcinoma, tend to be hyper-
vascular. Of note, islet cell tumours also may be hyper-
vascular. The pancreatic recurrence of renal cell carcinomaFigure 10. A 70-year-old woman with a history of renal cell carcinoma 6
years earlier. Axial reconstruction of contrast-enhanced computed tomog-
raphy shows hypervascular metastatic deposit consistent with renal cell
metastasis in the left-sided adductor muscle (black arrow).often occurs several years after the intended curative
nephrectomy and so suspicion must always be high for
metastatic disease in patients with a history of nephrectomy
for renal cancer.Splenic MetastasesSimilar to the pancreas gland, metastatic disease, of any
variety, to the spleen is quite rare, and splenic deposits of
recurrent renal cell carcinoma are described on a case report
basis (Figure 4) [9].Bilateral Adrenal MetastasesAdrenal metastases (Figure 5) from renal cancer are rela-
tively uncommon andmay develop in up to 10%of patients [6].
Bilateral adrenal metastases are extremely rare and, again, are
described largely on a case report basis in the literature [10].Gallbladder MetastasesMetastatic disease in the gallbladder is quite rare, but soft
tissue nodularity within this organ should raise suspicion
(Figure 6), particularly in a patient with a history of malig-
nant melanoma, gastric cancer, or, indeed, renal cell carci-
noma [11], which represent the more common of case
reported examples.
Ampullary Metastases
Late metastasis of renal cell carcinoma to the ampulla of
Vater (Figure 7), presenting clinically as obstructiveFigure 11. Coronal reconstruction of contrast-enhanced computed tomog-
raphy in a patient with a history of left nephrectomy for renal cell carcinoma
5 years earlier. An enhancing soft tissue mass within the right gluteal
muscles (black arrows) consistent with hypervascular metastases from his
known renal cancer.
Figure 12. (A) A 50-year-old man with history of nephrectomy for renal cell carcinoma 2 years earlier, presented with a mass over the anterior aspect of the
lower limb. T2-weighted magnetic resonance imaging, axial reconstruction, showing high signal mass within the tibialis anterior muscle (white arrow). Biopsy
confirmed recurrence of this patient’s original renal tumour. (B) Spot image from lower limb angiography in the same patient, demonstrating the hyper-
vascularity of this tibialis anterior based renal cell carcinoma metastasis (black arrow).
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described on a case report basis in the literature. The
majority of reported cases have occurred after an extended
disease-free interval [12]. In general, the ampulla of Vater is
an unusual site for metastatic disease of any type.Figure 13. A 45-year-old woman with a background of von Hippel-Lindau
syndrome, who underwent nephrectomy for renal cell carcinoma 2 years
earlier. Sagittal T2-weighted magnetic resonance image of the brain,
showing infiltration of the clivus and posterior ethmoid air cells with tumour
mass (white arrow), consistent with renal cell metastasis.Large Bowel RecurrenceNephrectomy bed recurrence may involve adjacent large
or small bowel and may present clinically with rectal
bleeding, intussusception, or fistulation (Figure 8).Recurrence Along the Postoperative Drain SiteRecurrence of renal cell carcinoma along a previous post-
operative drain tract is quite an unusual finding (Figure 9). A
search of the literature confirms case reported examples of
other tumours, such as pancreatic [13], squamous cell cervical
and colorectal cancer, seeding and recurring along the tract of
a previous postoperative drain.Along a similar theme, port-site
subcutaneousmetastases have also been described for a variety
of tumours, including esophageal, gallbladder, and, indeed,
renal cell carcinoma.Unusual Sites of Skeletal Muscle Metastases
Skeletal muscle metastases as distinct entities from renal
bed recurrence are quite rare and often asymptomatic
(Figures 10e12) [2]. Isolated metastases to skeletal muscle
have been described in numerous case reports. Erector spinae
is one of the more common sites [2], but careful attention
must be paid to all of the skeletal muscles, particularly on the
arterial phase of scanning. As with metastases in other
locations, unifocal disease with a longer recurrence-free
Figure 14. (A) Expansile, lytic bony metastasis (black arrow) demonstrated on plain film, at the proximal phalanx of the third digit in this patient with a history
of nephrectomy for renal cell carcinoma 3 years earlier. Amputation specimen confirmed the recurrence of this patient’s renal cell carcinoma. (B) T1-weighted
magnetic resonance image of the hand of this same patient, showing a low signal soft tissue mass at the site of bony destruction (black arrow).
Figure 15. Expansile, lytic bony metastasis (white arrow) of the fifth metacarpal demonstrated on plain film in this patient with a history of nephrectomy for
renal cell carcinoma 2 years earlier.
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Figure 16. A 70-year-old woman with a known history of renal cell carci-
noma, surgically resected 4 years earlier. Sagittal reconstruction of contrast-
enhanced computed tomography reveals hypervascular breast deposit (white
arrow), clinically palpable as a mass.
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curative treatment.Unusual Bony MetastasesExpansile, lytic bony metastases are common with renal
cell carcinoma and typically involve the axial skeleton,especially from T12 to the pelvis (Figures 13e15) [2]. Rib
involvement is not uncommon. More unusual bony locations
should also be suspected in the patient with a history of renal
cell carcinoma, prompting more focused attention to the
bony windows on routine follow-up imaging. Examples
diagnosed in our institution include bony metastases to the
clivus, an isolated phalangeal metastasis, and an expansile
lytic metacarpal metastasis. A single other case report of
renal cell carcinoma metastasizing to the clivus was found in
the literature [14].Breast RecurrenceMetastases within the breast from any nonmammary
primary and which may clinically be confused with
a primary breast carcinoma, have been described very rarely
in the literature (Figure 16) [15]. However, in patients with
a history of nephrectomy for renal cell carcinoma, the finding
of a new breast lump should at least raise the suspicion of
metastatic disease.Parotid MetastasisMetastatic disease to the parotid (Figure 17) is again quite
rare, particularly from neoplastic processes below the clav-
icle. Renal cell carcinoma metastases to the parotid are
described on a case report basis.Pituitary RecurrenceBrain metastases from renal cell carcinoma typically
appear as multiple enhancing nodules. Isolated metastases to
the pituitary gland are very uncommon (Figure 18).Testicular RecurrenceMetastatic disease to the testes and adnexal structures is
also quite rare, and metastases from a renal cell primary is
still largely described on a case report basis (Figure 19) [16].
Reports of both ipsilateral and contralateral testicular
recurrence highlights again the unpredictability of renal cell
carcinoma in its mode of spread.Conclusion
Renal cell carcinoma is an unpredictable tumour in both
its initial manifold clinical presentations and in its mode of
spread. Strong clinical suspicion of metastases is required in
the setting of new symptoms and clinical findings in a patient
with a background of nephrectomy for renal cell carcinoma,
however historic. The principle imaging tool to be used in
follow up of these patients is contrast-enhanced CT, ensuring
both arterial and venous phases are reviewed to optimize
detection of hypervascular metastases.
Figure 17. A 50-year-old patient with a known history of nephrectomy for renal cell carcinoma 4 years earlier. Computed tomography shows the soft tissue
mass (white arrow) in the parotid gland, which corresponds with the focus of increased radioisotope uptake on positron emission tomography (black arrow),
consistent with the presence of tumour. Parotid biopsy was undertaken, and recurrence of the patient’s clear cell renal cancer was confirmed on histology. This
figure is available in colour online at http://carjonline.org/.
Figure 18. (A) Sagittal reconstruction of post-contrast T1-weighted magnetic resonance image (MRI) of the brain, showing a large, enhancing mass within the
pituitary fossa (black arrow) in this patient with a history of renal cell carcinoma 5 years earlier. The finding is consistent with hypervascular metastasis.
(B) Coronal reconstruction, postcontrast, T1-weighted MRI of the same patient, demonstrating enhancing pituitary mass (black arrow), consistent with renal
cell carcinoma recurrence.
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Figure 19. (A) A 74-year-old man who had undergone left nephrectomy 1 year earlier for renal cell carcinoma developed a painless left scrotal lump, shown
here on ultrasound (black arrow). (B) Gross resection specimen of left scrotal contents of this same patient. Histology confirmed the presence of metastatic
renal cell carcinoma in the spermatic cord (black arrow) and rete testis. This figure is available in colour online at http://carjonline.org/.
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